Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anete Trajman

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Cadernos De Saude Publica|September 12, 2019
Rare diseases: who pays which bill?Anete Trajman
The Lancet. Infectious Diseases|August 17, 2023
The social drivers of tuberculosis, reconfirmedAnete Trajman
Current Opinion in Pulmonary Medicine|April 9, 2010
Occupational respiratory infectionsAnete Trajman, Dick Menzies
The Lancet. Infectious Diseases|January 9, 2017
It takes more than a sensitive test to find more tuberculosis casesAnete Trajman, Frank Cobelens
The European Respiratory Journal|December 22, 2018
New short regimens for latent tuberculosis treatment: safety first!Dick Menzies, Anete Trajman
The Lancet. Infectious Diseases|June 13, 2016
Active tuberculosis case finding-do we have the right tool?Anete Trajman, Dick Menzies
The Lancet. Infectious Diseases|December 14, 2020
Improving diagnosis of tuberculosis in childrenAnete Trajman, Kevin Schwartzman
BMC Infectious Diseases|April 17, 2015
Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort studyJosé Ueleres Braga, Anete Trajman
Nature Medicine|April 22, 2026
The ghost of tuberculosis pastAnete Trajman, Jonathon R Campbell
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 12, 2022
Four months of rifampicin for tuberculosis prevention treatment in childrenAnete Trajman, Thierno Diallo, Dick Menzies
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Cadernos De Saude Publica|September 12, 2019
Rare diseases: who pays which bill?Anete Trajman
The Lancet. Infectious Diseases|August 17, 2023
The social drivers of tuberculosis, reconfirmedAnete Trajman
Current Opinion in Pulmonary Medicine|April 9, 2010
Occupational respiratory infectionsAnete Trajman, Dick Menzies
The Lancet. Infectious Diseases|January 9, 2017
It takes more than a sensitive test to find more tuberculosis casesAnete Trajman, Frank Cobelens
The European Respiratory Journal|December 22, 2018
New short regimens for latent tuberculosis treatment: safety first!Dick Menzies, Anete Trajman
The Lancet. Infectious Diseases|June 13, 2016
Active tuberculosis case finding-do we have the right tool?Anete Trajman, Dick Menzies
The Lancet. Infectious Diseases|December 14, 2020
Improving diagnosis of tuberculosis in childrenAnete Trajman, Kevin Schwartzman
BMC Infectious Diseases|April 17, 2015
Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort studyJosé Ueleres Braga, Anete Trajman
Nature Medicine|April 22, 2026
The ghost of tuberculosis pastAnete Trajman, Jonathon R Campbell
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 12, 2022
Four months of rifampicin for tuberculosis prevention treatment in childrenAnete Trajman, Thierno Diallo, Dick Menzies
Pageof 14